Gail Boudreaux on strategic priorities
From Elevance Health AGM 2026 | Adjusted EPS Guidance Raised To $26.75 Following Strong Q1 Performance · · Investing 101
“In 2026, we're sharpening execution in three areas. First, we're prioritizing initiatives that deliver measurable impact on cost, quality, and experience while keeping our members at the center of every decision. Second, we're simplifying how work gets done, reducing complexity, increasing speed, and strengthening accountability. And third, we're operating as a more integrated technology enabled health partner, including scaling AI responsibly across our operations to improve engagement, manage medical costs, and support better outcomes.”
On , Gail Boudreaux, President, Chief Executive Officer & Director at Elevance Health Inc, spoke about strategic priorities during Elevance Health AGM 2026 | Adjusted EPS Guidance Raised To $26.75 Following Strong Q1 Performance on Investing 101.
About Gail Boudreaux
Gail Boudreaux, president and CEO of Elevance Health, reported at the company's 2026 annual meeting that Elevance Health generated $197.6 billion in operating revenue in 2025, a 13% increase from the prior year, and returned $4.1 billion to shareholders through dividends and share repurchases. She said the company was advancing its "whole health" approach by integrating physical, behavioral, pharmacy, and social care and scaling the use of artificial intelligence across operations. Boudreaux also noted that a shareholder proposal requesting an independent study on the impact of prohibiting corporate contributions to partisan political groups did not pass. During previous earnings calls in 2025, Boudreaux discussed challenges in the Medicaid and ACA markets. In the second quarter, she revised the full-year 2025 adjusted EPS guidance to approximately $30, citing elevated medical cost trends and slower-than-expected Medicaid rate alignment. She also described legal action against what she described as misuse of the independent dispute resolution process under the No Surprises Act, alleging that out-of-network providers had submitted inflated payment requests. In the third quarter, Boudreaux stated that Elevance Health was planning for at least a 125 basis point year-over-year decline in Medicaid margins and noted that if Congress allowed enhanced premium tax credits to expire, it would significantly impact 2026 membership. She emphasized that the company was prioritizing long-term performance over near-term expense leverage.